Wordt geladen...
5-(Bis(3-(2-hydroxyethyl)-1H-indol-2-yl)methyl)-2-hydroxybenzoic acid (BHIMHA): showing a strategy of designing drug to block lung metastasis of tumors
Early metastasis is still the most recalcitrant factor in the treatment of lung cancer patients. By analyzing the structures and comparing the docking scores of the known pharmacophores, the authors of this paper designed 5-(bis(3-(2-hydroxyethyl)-1H-indol-2-yl)methyl)-2-hydroxybenzoic acid (BHIMHA)...
Bewaard in:
Gepubliceerd in: | Drug Des Devel Ther |
---|---|
Hoofdauteurs: | , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Dove Medical Press
2016
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4762582/ https://ncbi.nlm.nih.gov/pubmed/26937173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S93570 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|